98959-89-8

Usage

Uses

Used in Pharmaceutical Synthesis:
(4-(Ethylsulfonyl)phenyl)methanamine hydrochloride is used as a reagent in the pharmaceutical industry for the synthesis of medications. Its unique chemical properties and structure contribute to the development of new drugs and therapeutic agents.
Used in Agrochemical Synthesis:
In the agrochemical industry, (4-(ethylsulfonyl)phenyl)methanamine hydrochloride is employed as a reagent in the synthesis of various agrochemicals. Its application aids in the creation of products that can enhance crop protection and agricultural productivity.
Used in Research Applications:
(4-(Ethylsulfonyl)phenyl)methanamine hydrochloride is also utilized in research settings for the study and development of new chemical compounds and materials. Its properties make it a valuable tool for scientific exploration and innovation in various fields.

Upstream product

• 583837-94-9 (4-(ethylsulfonyl)phenyl)methanamine 
• 409112-19-2 4-(ethylsulfonyl)benzonitrile 
• 90561-19-6 1-(bromomethyl)-4-(ethylsulfonyl)benzene 
• 7569-34-8 ethyl p-tolyl sulfone 

Relevant academic research and scientific papers

COMPOUNDS AS MODULATORS OF ROR GAMMA

The present invention encompasses compounds of the formula (I)(I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

SUBSTITUTED MORPHOLINE DERIVATIVES AS ROR GAMMA MODULATORS

The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, R1, R2, R3, X1, X2, m and n are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (RORyt). These compounds prevent, inhibit, or suppress the action of RORyt and are therefore useful in the treatment of RORyt mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, psoriasis, neurodegenerative diseases and cancer. (I)

AZAINDOLE COMPOUNDS AS MODULATORS OF RORC

The present invention encompasses compounds of the formula (I), wherein the variables are defined herein which are suitable for the modulation of RORC and the treatment of diseases related to the modulation of RORC. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

BICYLIC COMPOUNDS AS MODULATORS OF RORGAMMA

The present invention encompasses compounds of the formula (I): wherein the variables are defined herein which are suitable for the modulation of RORC and the treatment of diseases related to the modulation of RORC. The present invention also encompasses

COMPOUNDS AS MODULATORS OF ROR GAMMA

The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.